openPR Logo

Press Releases from Biomarkers (1 total)

Innovative Drivers and Trends : Non-alcoholic Steatohepatitis (NASH) Biomarkers …

ALBANY, NY, May 26, 2017 : Non-alcoholic steatohepatitis (NASH) is liver disease which is categorized under the spectrum of non-alcoholic fatty liver disease (NAFLD). NASH is an advanced form of NAFLD where the liver inflammation occurs owing to fat deposition in liver. The fat accumulation may be induced by genetic abnormalities, metabolic dysfunction, drug induced damages, etc. Untreated and advanced NASH is one of the major reason for liver cirrhosis

Go To Page:   1 2 3 4 5 6 7 8 9 10